2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia

BACKGROUND: Outcomes are improved with ceftazidime–avibactam (CZA) compared with polymyxin-based regimens (PBR) for carbapenemase-producing carbapenem-resistant Enterobacteriaceae. It is unclear whether this finding is true in non-carbapenemase (non-CP) producing CRE. The purpose of this study was t...

詳細記述

保存先:
書誌詳細
出版年:Open Forum Infect Dis
主要な著者: Borjan, Jovan, Shelburne, Samuel A, Bhatti, Micah M, Aitken, Samuel L
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811329/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1924
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料